Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/312618 
Year of Publication: 
2021
Citation: 
[Journal:] REGION [ISSN:] 2409-5370 [Volume:] 8 [Issue:] 2 [Year:] 2021 [Pages:] 57-81
Publisher: 
European Regional Science Association (ERSA), Louvain-la-Neuve, Belgium
Abstract: 
We investigated the role of public funding in cardiovascular device innovation across 31 countries in Europe. We rely on the knowledge production function (KPF) framework that establishes the knowledge output of a region as a function of innovatory effort and other characteristics of that region. In a cross-sectional analysis, we investigated regional variation in knowledge production by the number of publications in cardiovascular device research obtained from the bibliometric data of the world's largest biomedical library, the US National Library of Medicine, 2014-2017. We mapped these publications to product categories of medical devices approved for cardiovascular diseases by the US Food and Drug Administration. Considering spatial correlation across regions of Europe in our estimates of the KPF, we investigated the impact of two types of public funding mechanisms: the volume of European Union (EU) Framework Programme (FP) 7 funding received by the innovating regions and that of its successor the EU Horizon 2020 funding. We obtained 123,487 cardiovascular device-related publications distributed across 1,051 (75% of total) regions (NUTS-3 level). Receiving public funding strongly contributes to a region's knowledge output. The estimated elasticities of innovatory effort by FP7 range between 0.36 and 0.40 while the estimated elasticities of Horizon 2020 range between 0.13 and 0.17. Estimated elasticities remain robust after controlling for country level fixed effects. When accounting for additional inputs to the KPF by private funding and health system related factors, the elasticity estimates for FP 7 and Horizon 2020 reduced, but remained significant. We documented spillover from neighboring regions, albeit at small scale. Our results conclude that innovatory efforts in the form of public research investments are effective for promoting innovation in the medical device industry at the regional level.
Subjects: 
Innovation
Regional Innovation System
Medical Technology
Cardiovascular Devices
Innovatory Spillover
Spatial Spillover
JEL: 
R11
R12
O32
O52
Persistent Identifier of the first edition: 
Creative Commons License: 
cc-by-nc Logo
Document Type: 
Article

Files in This Item:
File
Size





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.